Background. Many factors can impair haemodialysis (HD) tolerance. Some such as age and diabetes mellitus are linked to the patient. Others, such as dialysate, machine, and membrane are linked to the treatment characteristics. The duration of the HD sessions may represent another factor in tolerance since it influences the rate of ultrafiltration. However, its influence has not been studied independently of the type of membrane or dialysate buffer. Methods. In a randomized crossover study, the incidence of intradialytic symptoms was compared during 4-h and 5-h HD sessions in 38 patients. The study period was 2 weeks for each dialysis time. The influence of age and diabetes was also analysed. Sessions requiring more than 4 litres of ultrafiltration were excluded. Results. During the 5-h period, the incidence of headache, nausea, chills, back pain and pruritus was significantly greater. On the contrary, the incidence of hypotension and postdialytic orthostatic hypotension was significantly less. We also demonstrated that ultrafiltration rate and orthostatic hypotension were correlated, and that age over 65 years and diabetes influenced HD tolerance. The incidence of hypotension was significantly less in patients over 65 receiving 5-h HD treatment. Conclusions. Although some symptoms were more frequent during the 5-h HD sessions, the incidence of hypotension and postdialytic orthostatic hypotension was significantly less. This resulted in an improvement in acute haemodynamic HD tolerance, which could also influence long-term morbidity and mortality, especially in patients over 65 years.
Introduction
Haemodialysis tolerance usually includes all the symptoms that can occur during the haemodialysis session or during the few hours after the end of the session: essentially hypotension, but also muscle cramps, nausea, vomiting, headache, back pain, chest pain, itching, fever, chills, and restlessness.
Many factors can impair haemodialysis tolerance. Some of them are linked to the patient: age, cardiac disease, diabetes mellitus, anaemia, antihypertensive medications, autonomic nervous system dysfunction, weight gain during the interdialytic period, and hypocalcaemia [1] [2] [3] [4] [5] . Others are linked to the treatment characteristics: acetate buffer, uncontrolled ultrafiltration, bacterial contamination of the dialysate, type of membrane material, dialysate sodium concentration, and dialysate temperature [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . The duration of the haemodialysis sessions may represent another factor in haemodialysis tolerance since it influences the rate of ultrafiltration. Short sessions could lead to the removal of fluid from the intravascular space at a rate that exceeds the refilling capacity from the interstitial space.
In most facilities, haemodialysis treatment time was gradually decreased from 24 h per week in the 1970s to 12 h per week in the 1980s. Sometimes treatment time was reduced even more. These reductions were made possible through improvements of the haemodialysis apparatus (dialysers and machines).
The influence of haemodialysis duration on dialysis adequacy is well known. Moreover, some studies have focused on the effect of time on mortality and morbidity [16] [17] [18] [19] . Lastly, it has been suggested that the favourable effect of long dialysis on mortality is linked to good blood pressure control [20] . However, there are few studies on the influence of the duration of the haemodialysis session on tolerance, and this influence has not been studied independently of the type of dialyser or the type of buffer [21] . Here, we propose to analyse independently the influence of haemodialysis treatment time on clinical tolerance in a randomized crossover study, comparing 4-h and 5-h sessions.
Subjects and methods

Patients
All patients treated for 15 h per week in our centre were initially selected. Patients were exluded if they had coronaropathy or if they did not give their consent to participate in the study. A total of 38 patients were included. All were in-centre chronic haemodialysis patients. Patients were aged 59 + 2 years (mean±SEM), range 28-76; the length of time on haemodialysis treatment was 71 + 11 months, range 2-240; 16 were women and 22 were men. Initial nephropathy was chronic glomerulonephritis (n = 7), interstitial (n = 7), vascular (w = 9), diabetic (« = 8), hereditary (n=4), and undetermined 0 = 3). rHuEpo was administrered to 17 patients (45%); 14 patients (37%) received antihypertensive drugs.
Haemodialysis treatment characteristics
All patients were dialysed with volumetrically controlled machines (AK 100, Gambro, Lund, Sweden). Dialysate sodium concentration was 140 mmol/1 in 29 patients, greater than 140 in eight patients, and less than 140 in one patient. Bicarbonate dialysate concentration was 34 mmol/1 in 26 patients, greater than 34 in three patients and less than 34 in nine patients. Dialysate contained no glucose, except for diabetic patients treated with insulin. The other constituents of the dialysate had the following concentrations: potassium 2 mmol/1; calcium 1.75 mmol/1; magnesium 0.75 mmol/1; acetate 3 mmol/1. Endotoxin counts were always less than 0.010 EU/ ml. Temperature of dialysate was 37°C. The rate of dialysate flow was 500 ml/min in all cases. Blood flow rate was 250 ml/min (« = 31), 200 ml/min (n=4), or 300 ml/min (« = 3). The ultrafiltration rate was maintained constant during the session. The type of membrane was cellulose acetate in 21 cases, cellulose diacetate in 10 cases and polysulphone in seven cases. Anticoagulant was heparin in all cases. Food ingestion was not avoided during session. Dialysis treatment parameters and medications were kept constant for each patient throughout both phases of the study.
Study design
We used a randomized crossover study to analyse the incidence of symptoms in relation with 5-h or 4-h dialysis sessions. The study period was 2 weeks for each dialysis time. Patients were randomized to inclusion in group A, receiving 5-h dialysis sessions first, and group B, receiving 4-h dialysis sessions first. A session was excluded from the study when the difference between predialysis body weight and 'dry' body weight led to an ultrafiltration volume greater than 4 litres. In these cases, the usual protocols of isolated ultrafiltration or increased session duration were used. We also excluded sessions with unexpected excessive ultrafiltration (postdialysis weight more than 0.5 kg under 'dry' weight).
Parameters studied
Blood pressure was clinically measured at 1-h intervals and upon the occurrence of symptoms. Hypotension was defined as a systolic blood pressure (SBP) less than lOOmmHg or, when predialysis SBP was less than HOmmHg, by a 30% reduction of the initial value. Orthostatic hypotension was defined as an orthostatic reduction of SBP > 25 mmHg. The 47 following parameters were recorded during each session: (1) symptoms such as malaise, headache, cramps, nausea, vomiting, chills, chest pain, back pain, dyspnoea, pruritus, hypotension, postdialysis orthostatic hypotension, and the amount of saline administered, (2) patient scores for general intradialytic and postdialytic wellbeing on a scale from 0 to 10 (0 = maximal discomfort; 10 total wellbeing), (3) volume of ultrafiltration. Serum urea was measured every week before and after each midweek dialysis session. Kt/V urea was estimated from the formula 1.2 xLn (post/pre-urea).
Statistical analysis
Analyses were performed on the percentage of sessions with occurrence of symptoms. Results are expressed as the mean + SEM. Comparisons were made using Wilcoxon's test. A level of / > <0.05 was considered as significant. The influence of other parameters (diabetes, age, type of membrane, sex, and antihypertensive medications) on symptoms during the whole study period was analysed by analysis of variance.
Results
The mean number of sessions studied per patient was 10.7 + 0.3 over 12. The global incidence of sessions with symptoms per patient during the whole period of the study is presented in Table 1 . The most frequent symptom was pruritus, 24+6% of the sessions. Other frequent symptoms were cramps and headache respectively 13 + 3% and 11 + 3% of the sessions. Malaise was present in 7 ±2%, hypotension in 7 ±2%, and orthostatic hypotension in 9 + 2% of the sessions.
For the proportion of patients with symptoms, we found that cramps occurred in 50% of them, pruritus and headache in 42%, malaise in 39%, fall in blood pressure in 37%, and orthostatic hypotension in 42% ( Table 2 ).
The comparison of the 4-h and 5-h periods is presented in Table 3 . The mean number of studied sessions was not different during the 4-h period and the 5-h period. The incidence of headache, nausea, chills, back pain and pruritus was higher during the 5-h period. The perdialytic wellbeing score was also higher during the 5-h period (/ > =0.03). On the contrary, the incidence of hypotension and postdialytic orthostatic hypotension significantly decreased during the 5-h period.
The mean weight gain was similar in the two study periods: 2.11 kg during the 4-h period and 2.13 kg during the 5-h period. Thus the mean rate of ultrafiltration was 0.53 1/h during the 4-h period and 0.43 during the 5-h period (P<0.0001). The analysis of relationships between ultrafiltration rate and symptoms revealed a significant relationship with orthostatic hypotension (OH): 0.55 + 0.03 during sessions with OH and 0.47 + 0.01 during sessions without OH (P= 0.03). An influence of ultrafiltration rate on emesis was found at the limit of the significance (Z' = 0.05).
Then we analysed the influence on haemodialysis
tolerance of other parameters: diabetes, age, sex, type of dialysis membrane, and treatment with antihypertensive medications. When the eight patients with diabetic nephropathy were studied separately (Table 4) , headache, nausea, vomiting, and orthostatic hypotension were more frequent in this group. Analysis of the influence of treatment duration on diabetic patients showed no difference between 4 h and 5 h ( Table 5 ). The influence of age was analysed by separating the 20 patients under 65 years from the 18 over that age (Table 6 ). There was a significant increase in the mean incidence orthostatic hypotension (P = 0.02) and a decrease in the postdialytic wellbeing score (P=0.03) in the older-patient group. In this group, 5-h dialysis time led to an increase in the incidence of headache and pruritus and to a significant decrease in hypotension (Table 7) . For the influence of sex, it was found that hypotension occurred more frequently in females (i>=0.04). Lastly, no influence of the type of membrane or antihypertensive medications was demonstrated. The adequacy of treatment was assessed by calculing the Kt/V urea obtained from pre-and post-dialysis sampling during the midweek session. As expected, Kt/V urea was significantly higher during the 5-h period than during the 4-h period (1.49 + 0.20 versus 
Discussion
This prospective crossover study evaluated the influence of 4-h versus 5-h sessions on haemodialysis tolerance. It is shown that during 5-h treatments symptoms such as headache, cramps, nausea, chills, back pain, and pruritus were more frequent than during 4-h treatments. On the contrary, hypotension and postdialytic orthostatic hypotension were less frequent, indicating a better haemodynamic acute tolerance.
Mean interdialytic weight gain was similar during the two periods. Thus the rate of ultrafiltration was significantly less during 5-h sessions. We observed a significant correlation between the rate of ultrafiltration and the incidence of postdialysis orthostatic hypotension. This symptom may prevent some patients from leaving the dialysis unit. It often necessitates administration of saline or salty foods. Moreover it could force patient to rest after going back home. Lastly it could lead to increased morbidity and lack of rehabilitation in patients with regular high interdialytic weight gain.
At the beginning of this study we thought that 5-h treatments would be much better tolerated than 4-h treatments because we supposed that the ultrafiltration rate was one of the main determinants of haemodialysis tolerance. The relatively good tolerance of 4-h treatment period could be explained in part by the fact that we excluded sessions with high interdialytic weight gain leading to the need of an ultrafiltration volume greater than 4 litres. Another explanation is that patients were treated on volumetrically controlled machines and with bicarbonate buffer. These technical characteristics have been shown to improve haemodynamic tolerance of haemodialysis [14] . The good tolerance of haemodialysis in this study is apparent from the rate of symptoms such as hypotension, recorded in only 6% of the sessions. In the literature, hypotension is reported to occur in 15-50% of the sessions [22] .
It should be noted that the symptoms that occurred significantly more frequently during 5-h dialysis period are subjective. This suggests that they are linked to psychological effects and worse acceptance. Of course, 5-h dialysis time leads to longer immobilization. However, we cannot rule out the influence of longer contact (5 h rather than 4 h) between blood and dialysis materials and dialysate. The lack of beneficial effect of long dialysis sessions on pruritus could be due in part to the limited duration of the study. Actually it has been shown that increased dialysis efficacy reduces the pruritus in haemodialysed patients after a period of 3 months [23] .
The relationship between haemodialysis session duration and tolerance has not been independently examined in the literature. In a large study [21] , tolerance was compared for 'conventional-time' sessions (191 + 5 min) and 'short-time' sessions (147 + 5 min). It was concluded that shorter treatment times were not associated with an increase in intradialytic complications. In that study, however, 'conventional-time' sessions were performed with low-flux cellulose-based dialysers and acetate dialysate whereas 'short-time' sessions were performed with bicarbonate dialysate, high-flux polysulphone dialysers and volumetrically controlled machines. It is obvious that the better tolerance of shorter treatment time was mainly linked to bicarbonate buffer and controlled ultrafiltration.
Many factors can influence haemodialysis tolerance. Some of them are related to the patient status. In elderly patients, hypotension occurs more frequently and the amount of fluid volume that can be safely ultrafiltered is limited [2] . In diabetic patients, an increase in episodes of hypotension, nausea, and vomiting during haemodialysis compared with non-diabetics was reported [4] . Hypotension may also occur more frequently in patients with left ventricular dysfunction [3] . In our study we found a significant influence of diabetes and age over 65 years on dialysis tolerance. Perdialytic symptoms were more frequent in patients over 65 and in diabetics. Moreover, in those over 65, hypotension was more frequent during 4-h than during 5-h treatments. This result can be linked with the analysis of the EDTA registry, which demonstrated that patients over 65 receiving more than 12 h treatment per week had a lower grade of mortality rate than the patients receiving 12 h or less [19] .
Other factors influencing haemodialysis tolerance are linked to the procedure. Many studies have related symptoms occurring in haemodialysis with biochemical and cellular phenomena induced by blood-cellulose membrane interactions [12, 24] , and particularly with complement activation [25] , cytokine release [13] , and oxygen free-radical generation [26] . These studies showed that these phenomena are reduced with synthetic membranes. However, two recent clinical studies reported that the influence of synthetic membranes on tolerance was not more favourable than that of cellulose membranes [27, 28] . Our results are in accordance with these studies as no influence of the type of membrane on tolerance was observed.
The dramatic influence of increase in session duration on dialysis efficiency measured by the Kt/V urea was not surprising, and indicates that long dialysis sessions should be prescribed.
In conclusion, this study demonstrated an inverse profile of incidence of symptoms during 4-h and 5-h dialysis treatments in a selected population. During 5-h dialysis, symptoms which could be considered as subjective were more frequent, but hypotension and postdialysis orthostatic hypotension were less frequent. Moreover, hypotension was less frequent during 5-h dialysis when patients over 65 were studied separately. Thus, besides the good results they show in long-term morbidity and mortality studies, long dialysis times probably lead to an improvement in acute haemodynamic tolerance of dialysis, mediated by the ultrafil-P. Brunet et al.
tration rate. Our results may partly explain the lower morbidity and mortality observed with long dialysis, especially in patients over 65.
